MARKET

NTUS

NTUS

Natus Medical
NASDAQ

Real-time Quotes | Nasdaq Last Sale

24.86
+0.28
+1.14%
Closed 18:34 09/27 EDT
OPEN
25.38
PREV CLOSE
24.58
HIGH
25.45
LOW
24.47
VOLUME
142.78K
TURNOVER
--
52 WEEK HIGH
29.70
52 WEEK LOW
16.60
MARKET CAP
848.49M
P/E (TTM)
468.70
1D
5D
1M
3M
1Y
5Y
Natus Medical Awarded Key New Government Contract; Terms Not Disclosed
Natus Medical Incorporated (NASDAQ:NTUS) (the "Company" or "Natus"), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system
Benzinga · 14h ago
Natus Medical Secures Inclusion in Government Electronic Catalog
MT Newswires · 18h ago
4 Small-Cap Medical Device Stocks Rated 'Strong Buy'
StockNews.com · 08/25 13:51
Return on Capital Employed Overview: Natus Medical
After pulling data from Benzinga Pro it seems like during Q2, Natus Medical (NASDAQ:NTUS) earned $6.01 million, a 33.05% increase from the preceding quarter.
Benzinga · 08/20 18:41
Natus Medical (NTUS) Q2 Earnings Match Estimates
Zacks.com · 08/05 22:05
Natus Medical EPS in-line, beats on revenue
Natus Medical (NASDAQ:NTUS): Q2 Non-GAAP EPS of $0.29 in-line; GAAP EPS of $0.10 misses by $0.07. Revenue of $115.97M (+36.8% Y/Y) beats by $0.87M. Press Release
Seekingalpha · 08/05 20:46
Natus Medical Announces Second Quarter 2021 Financial Results
Q2-2021 Key ResultsRevenue (millions)$116.0 • Revenue increased 37% compared to Q2 2020• Generated $19.4 million in operating cash flow• GAAP and Non-GAAP EPS increased by $0.36 and $0.42, respectively compared to Q2 2020GAAP EPS$0.10 Non-GAAP EPS$0.29 PLE...
GlobeNewswire · 08/05 20:01
-- Earnings Flash (NTUS) NATUS MEDICAL INCORPORATED Posts Q2 EPS $0.45, vs. Street Est of $0.29
MT Newswires · 08/05 16:19
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of NTUS. Analyze the recent business situations of Natus Medical through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
0.00%Buy
100.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average NTUS stock price target is 36.00 with a high estimate of 36.00 and a low estimate of 36.00.
High36.00
Average36.00
Low36.00
Current 24.86
EPS
Actual
Estimate
0.100.200.290.39
Q3 2020
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Institutional Holdings
Institutions: 260
Institutional Holdings: 35.52M
% Owned: 104.08%
Shares Outstanding: 34.13M
TypeInstitutionsShares
Increased
57
1.55M
New
28
764.20K
Decreased
53
2.16M
Sold Out
14
541.16K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
-2.19%
Healthcare Equipment & Supplies
-1.88%
Key Executives
Non-Executive Chairman/Independent Director
Joshua Levine
President/Chief Executive Officer/Director
Jonathan Kennedy
Chief Financial Officer/Executive Vice President/IR Contact Officer
B. Drew Davies
Executive Vice President
Austin Noll
Vice President
D. Christopher Chung
Independent Director
Ilan Daskal
Independent Director
Eric Guerin
Independent Director
Lisa Heine
Independent Director
Bryant Moore
Independent Director
Alice Schroeder
Independent Director
Thomas Sullivan
No Data
About NTUS
Natus Medical Incorporated provides healthcare solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages. The Company provides product solutions for three end markets: Neuro, Newborn Care and Hearing & Balance. Its Neuro includes products and services that provide diagnostic, therapeutic and surgical solutions in neurodiagnostics, neurocritical care and neurosurgery. Its Newborn Care includes products and services for newborn care, including hearing screening, brain monitoring, eye imaging, jaundice management and various disposable newborn care supplies. Its Hearing portfolio includes products for hearing assessment and diagnostics and hearing aid fitting, including computer-based audiological, otoneurologic and vestibular instrumentation for hearing care professionals. Its Balance portfolio provides diagnosis and assessment of vestibular and balance disorders.

Webull offers kinds of Natus Medical Inc stock information, including NASDAQ:NTUS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NTUS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NTUS stock methods without spending real money on the virtual paper trading platform.